EUVIMEDOpdag EUVIMED
Crossref

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives

A. Tzikas, T. Lewalter

Continuing Cardiology Education · 2016

DOI: 10.1002/cce2.18 ↗

At a glance

Journal article in Continuing Cardiology Education, 2016. Written by A. Tzikas and 1 co-authors. 15 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Left atrial appendage occlusion (LAAO) is a promising alternative to oral anti‐coagulation in patients with non‐valvular atrial fibrillation. Recently, four‐year results of PROTECT‐AF demonstrated superiority of LAAO in all‐cause mortality and stroke reduction compared to optimal medical treatment with warfarin. In this new era, it is important to identify the patients who would benefit more from LAAO and offer them priority for treatment. Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/4193475/Activity.aspx

Cite

APA

Tzikas, A., & Lewalter, T. (2016). Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives. Continuing Cardiology Education. https://doi.org/10.1002/cce2.18

Vancouver

Tzikas A, Lewalter T. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives. Continuing Cardiology Education. 2016. doi:10.1002/cce2.18

BibTeX
@article{Tzikas2016,
  author = {Tzikas, A. and Lewalter, T.},
  title = {Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives},
  journal = {Continuing Cardiology Education},
  year = {2016},
  doi = {10.1002/cce2.18}
}
Start for free →